Skin bacteria and fungi in light spots on the face
Part of Skin clinical trials.
This study looks at the bacteria and fungi living on the skin of people who have light-colored spots (hypopigmentation) on their face. It aims to understand what's different about the skin microbiome in these spots, which may help improve treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have light-colored spots on your face that a doctor has diagnosed as seborrheic macular hypopigmentation
- You are willing to not use certain skin products or treatments before the study visit
- You are not taking antibiotics or antifungal medicines (by mouth or on skin) in the weeks before the visit
- You have not had any facial procedures (like laser or peels) in the last 3 months
- You are not pregnant, breastfeeding, or under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a skincare formula for treating three types of dark spots on the face: melasma, acne marks, and age spots. It aims to see if the product is effective and gentle after 3 months of daily use.
This study tests a cosmetic cream to reduce dark spots on the face, including melasma and sun spots. It aims to see if the product improves the appearance of hyperpigmentation.
This study tests whether a facial sunscreen can reduce dark spots and pigmentation after 8 weeks of daily use. It may be a good option if you have age spots, melasma, or other dark marks on your face and want a simple, non-invasive treatment.
This study tests whether special cosmetic products can help improve dark marks on the skin (post-inflammatory hyperpigmentation) and boost self-esteem and quality of life in Black women. You'll use the cosmetics regularly and answer questions about how you feel.
This study tests a new cream for facial dark spots caused by sun damage, melasma, or acne. It aims to see if the cream is safe and effective over three months.
This study tests a new cream against a standard prescription cream (4% hydroquinone) to treat dark spots or melasma on the face. You will use a cream daily and avoid other skin treatments for about 4 months.
Hear when a new Hypopigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.